
Synaptrix Labs is dedicated to developing non-invasive brain-computer interfaces, particularly through their innovative product Neuralis, which aims to restore mobility and independence for individuals with severe neuromuscular conditions. Their technology leverages advanced neurotechnology and a powerful cloud compute architecture to translate user intentions into wheelchair maneuverability. Additionally, their Saffron-1 AI model enhances EEG signal detection and analysis, making it adaptable for various applications. With a strong multidisciplinary team and backing from renowned advisors, Synaptrix Labs is positioned to make significant advancements in assistive technology, focusing on accessibility and user-centric design.

Synaptrix Labs is dedicated to developing non-invasive brain-computer interfaces, particularly through their innovative product Neuralis, which aims to restore mobility and independence for individuals with severe neuromuscular conditions. Their technology leverages advanced neurotechnology and a powerful cloud compute architecture to translate user intentions into wheelchair maneuverability. Additionally, their Saffron-1 AI model enhances EEG signal detection and analysis, making it adaptable for various applications. With a strong multidisciplinary team and backing from renowned advisors, Synaptrix Labs is positioned to make significant advancements in assistive technology, focusing on accessibility and user-centric design.
Sector: AI-driven non-invasive brain–computer interfaces (BCI)
Flagship product: Neuralis (mind-controlled wheelchair)
Founded: 2023
HQ: New York, NY
Notable investor: Underdog Labs (recorded)
Assistive neurotechnology for paralysis and neurological conditions (EEG/EMG de-noising, assistive device control).
2023
Biotechnology Research
Public records indicate a Pre-Seed round recorded on this date with details obfuscated in the source.
“Underdog Labs recorded as an investor”
| Company |
|---|
About Synaptrix Labs Inc. Synaptrix is on a mission to revolutionize brain-computer interfaces through non-invasive approaches. We believe that the power to diagnose and treat neurological conditions safely, and to expand human potential, will become a reality with the right fusion of deep learning, signal processing, and computational neuroscience.
We're seeking a full time Clinical Partnerships & Neurophysiology Lead to bridge the worlds of clinical research, neuroscience, and strategic collaboration. This role combines hands-on clinical trial execution with relationship building across hospitals, rehabilitation centers, and academic institutions. You'll play a pivotal role in bringing our brain-computer interface technology, Neuralis™, to patients, while helping shape how Synaptrix engages the broader neurotechnology ecosystem.
Responsibilities:
Minimum Qualifications:
Preferred Qualifications:
About our Culture: At Synaptrix Labs, we celebrate curiosity, open collaboration, and scientific rigor. Our interdisciplinary team spans neuroscience, AI, and clinical research, and we are united by the belief that non-invasive BCI is the key to unlocking a new era in healthcare, accessibility, and human augmentation.
What We Offer: